AMR industry alliance

The collective industry voice on antimicrobial resistance

The AMR Industry Alliance is the collective voice of the life sciences sector on antimicrobial resistance. We bring together biotech, diagnostics, generics, and research-based pharmaceutical companies across the antibiotic life cycle, and we advocate for the policy, procurement, and practice changes needed to save lives.

companies &
associations
0 +

Why AMR Matters

Resistance is outpacing the medicines we have left.

Antimicrobial resistance is one of the top 10 global public health threats, according to the World Health Organization. Drug-resistant infections could directly cause 39 million deaths between 2025 and 2050, and as resistance spreads, the routine care that modern medicine depends on, from surgery to chemotherapy to childbirth, gets harder to deliver safely. The burden falls hardest on low- and middle-income countries, though no country is spared. It also reaches high-income countries, where health systems face shortages of generic antibiotics and limited access to newer medicines. This is a threat the world can still curb, and doing so takes coordinated effort across access and appropriate use, manufacturing, and research, with governments, health systems, and industry working together.

Focus Areas

Three commitments the industry can be measured on.

We work across the response to antimicrobial resistance, from responsible manufacturing to the wider policy and market changes it advocates for. In each area, we set out the industry’s role and press for the broader changes the response needs.

Access and Appropriate Use

Expanding access to the antibiotics people need and supporting the responsible use that keeps them working.

Manufacturing

Setting and independently certifying a common standard for responsible antibiotic production, so manufacturing does not drive resistance.

Research and Science

Tracking the decline in new antibiotics and backing the incentives needed to rebuild the pipeline.

Key Resources

Reports, standards and evidence

Reports, guidance, and policy positions from across our work.

Report

2024 Year in Review

The Alliance's periodic survey of industry action on AMR.

Download PDF

Manufacturing

Antibiotic Manufacturing Standard

The independently certifiable standard for responsible production.

Download PDF

Declaration

AMR Industry Declaration

The founding commitments Alliance members sign up to.

Download PDF

AMR in Numbers

Why action is urgent

The scale of the threat is clear, and so is the cost of treating it as tomorrow’s problem.

01

0 million

deaths drug-resistant infections could directly cause between 2025 and 2050 — around three every minute.

02

$ 0 trillion

AMR’s projected annual loss to global GDP by 2050 without action.

03

~ 0 %

of antimicrobial prescriptions worldwide are unnecessary or inappropriate — one of the drivers still within reach to change.

Latest Updates

News from the Alliance

The latest announcements, updates, and perspectives from the Alliance.

Feature

A Decade of Action on AMR: Reflections and Path to 2029

A decade after the Davos Declaration on AMR, sustained collaboration has driven innovation, strengthened stewardship, and expanded access to lifesaving antibiotics and diagnostics....

WAAW Webinar 2025

In recognition of 2025 World AMR Awareness Week, the AMR Industry Alliance held a webinar, “Building...

AMR Industry Alliance Releases “Principles for Pooled Procurement of AMR Products”

The AMR Industry Alliance is proud to announce the publication of its new guidance document: “Principles...

News, Press Release

AMR Industry Alliance Updates Responsible Manufacturing Standard, Further Aligning with WHO Guidance

  Geneva, Switzerland, 13 May 2025 — The AMR Industry Alliance today announced it has updated...

Get in touch

Whether you’re a member, a partner, or exploring how to engage,
we’d like to hear from you.